Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial
奥扎尼莫德治疗复发型多发性硬化症的长期安全性和有效性:DAYBREAK开放标签扩展试验的最终分析
期刊:Multiple Sclerosis Journal
影响因子:5
doi:10.1177/13524585251382796
Selmaj, Krzysztof W; Steinman, Lawrence; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L; Hartung, Hans-Peter; Montalbán, Xavier; Havrdová, Eva K; Sheffield, James K; Krakovich, Anthony; Cheng, Chun-Yen; Riolo, Jon V; Pachai, Chahin; Thorpe, Andrew; DeBoer, Erik; Kappos, Ludwig; Cohen, Jeffrey A; Cree, Bruce Ac